Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Open in API
Filings indexed 241 across all filing types
Latest filing 2022-08-31 Regulatory Filings
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
[기재정정]투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Voronoi) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically an amendment to a technology licensing agreement for new drug development. It details the nature of the contract, the parties involved, and the financial implications. Since this is a specific corporate announcement regarding a material business transaction (licensing agreement) and does not fit into categories like M&A (TAR) or capital changes (SHA), it falls under the general regulatory filing category for material corporate events.
2022-08-31 Korean
투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from the Korean company Voronoi regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically announcing a technology licensing agreement for new targeted therapeutics. This type of disclosure is a standard regulatory announcement for material corporate events in the Korean market, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, share issuance, or financial reports.
2022-08-29 Korean
투자판단관련주요경영사항(VRN07(ORIC-114) 관련 마일스톤 기술료 수령)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Voronoi) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the receipt of a milestone payment from a licensing agreement (ORIC Pharmaceuticals). Since this is a specific corporate event disclosure regarding financial milestones and business operations that does not fit into categories like earnings releases or annual reports, it falls under the general regulatory filing category.
2022-08-17 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Voronoi Inc., covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which are characteristic of an interim/quarterly report. It is not an announcement of a report, but the report itself. H1 2022
2022-08-12 Korean
투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Voronoi) titled 'Investment Judgment Related Major Management Matters'. It details a technology licensing agreement for a new targeted therapy. This type of disclosure, which reports a specific business transaction or material event (licensing agreement), falls under the category of general regulatory announcements for material events that do not fit into specific categories like M&A or share issues, thus it is classified as a Regulatory Filing (RNS).
2022-07-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including the addition of a new subsidiary's executive as a special related party. This falls under the category of 'Major Shareholding Notification' (MRQ).
2022-07-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.